Lv3
336 积分 2026-08-19 加入
Application and Expectations for Immune Checkpoint Blockade of LAG3 and TIGIT
1天前
已完结
Clinical advances of mRNA vaccines for cancer immunotherapy
1天前
已完结
Role of the microbiota in response to and recovery from cancer therapy
1天前
已完结
Lifileucel: the first cellular therapy approved for solid tumours
1天前
已完结
Combination Immunotherapy With Nivolumab Plus Ipilimumab in Melanoma of Unknown Primary
1天前
已完结
Tumor-Infiltrating Lymphocyte Therapy for the Treatment of Metastatic Melanoma
1天前
已完结
Current and emerging intralesional immunotherapies in cutaneous oncology
1天前
已完结
Therapeutic Strategies in BRAF V600 Wild-Type Cutaneous Melanoma
1天前
已完结
Mechanisms of resistance to immune checkpoint inhibitors in melanoma: What we have to overcome?
1天前
已完结
Safety of adoptive therapy with tumor-infiltrating lymphocytes and high-dose recombinant interleukin 2 in advanced cutaneous melanoma: a systematic review and meta-analysis
1天前
已完结
皖公网安备34019202002308
